Compare PRGO & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRGO | AZTA |
|---|---|---|
| Founded | 1887 | 1978 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2013 | 1996 |
| Metric | PRGO | AZTA |
|---|---|---|
| Price | $11.78 | $25.07 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $19.33 | ★ $40.60 |
| AVG Volume (30 Days) | ★ 3.1M | 842.8K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | ★ 10.16% | N/A |
| EPS Growth | N/A | ★ 60.52 |
| EPS | N/A | ★ N/A |
| Revenue | $800,000.00 | ★ $593,821,000.00 |
| Revenue This Year | N/A | $6.99 |
| Revenue Next Year | $1.02 | $5.98 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.23 | $19.87 |
| 52 Week High | $28.44 | $41.73 |
| Indicator | PRGO | AZTA |
|---|---|---|
| Relative Strength Index (RSI) | 61.27 | 59.18 |
| Support Level | $9.24 | $19.87 |
| Resistance Level | $15.08 | $32.32 |
| Average True Range (ATR) | 0.51 | 1.18 |
| MACD | 0.26 | 0.66 |
| Stochastic Oscillator | 95.35 | 91.64 |
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.